🇺🇸 RAYOS in United States
353 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 22 April 2025 – 22 April 2026
- Total reports: 353
Most-reported reactions
- Drug Ineffective — 63 reports (17.85%)
- Pain — 45 reports (12.75%)
- Off Label Use — 41 reports (11.61%)
- Fatigue — 35 reports (9.92%)
- Headache — 34 reports (9.63%)
- Nausea — 32 reports (9.07%)
- Dyspnoea — 31 reports (8.78%)
- Diarrhoea — 24 reports (6.8%)
- Insomnia — 24 reports (6.8%)
- Vomiting — 24 reports (6.8%)
Other Immunology / Rheumatology approved in United States
Frequently asked questions
Is RAYOS approved in United States?
RAYOS does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for RAYOS in United States?
Ampel BioSolutions, LLC is the originator. The local marketing authorisation holder may differ — check the official source linked above.